ClinicalTrials.gg
RecruitingNCT06140355Updated Aug 19, 2026

cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury

An interventional study of Qigong and Daily 2 min pain management survey in Spinal Cord Injuries, sponsored by University of Minnesota. Recruiting at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by University of Minnesota · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Spinal Cord Injuries by University of Minnesota — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Minnesota.

Planned enrollment
6th of 12
40 · median 38
Started
2024
with 1 other
No phase
8 of 15
4 open now
Registered
12th of 15
by date

Among the 15 studies in Spinal Cord Injuries by University of Minnesota, this one is the 6th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2024, is one of 8 with no phase, and was the 12th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

7 of the 15 studies in Spinal Cord Injuries by University of Minnesota are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Spinal Cord Injuries by University of Minnesota, or all of them as a file.
02

Study summary

Chronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Of the available mind and body approaches, Qigong is the most accessible for adults with SCI with evidence for effectiveness in reducing pain, but there is insufficient evidence to make recommendations for adults with SCI. Thus, the feasibility of Qigong in SCI needs to be established.

To support our feasibility study, we investigated a 12-week remote Qigong program in adults with SCI and neuropathic pain. We recruited 23 adults with SCI, 18 completed the study, and 12 completed the 1-year follow-up. They practiced Qigong 138% of the required intensity (which was, at least 3x/week with Qigong video through the internet). Their pain was reduced by 44% after 12 weeks of Qigong practice and was still reduced at the 6-week and 1-year follow-up. However, three key elements need to be addressed before performing a larger effectiveness study: (1) feasibility/acceptability of Qigong from adults with SCI of diverse backgrounds; (2) feasibility of the study design with control group); and (3) objective outcome measures.

This R34 feasibility study, the HAPPINESS trial (cHAnging the Perceived Pain INtensity in divErSe populations with Spinal cord injury), will expand on our prior study to consolidate feasibility with a rigorous protocol. We will address the following aims: AIM 1. Identify the facilitators/barriers to participating in a Qigong study through focus groups/interviews with stakeholders from diverse backgrounds, defined as Hispanics, veterans, and adults living in rural, underserved areas. AIM 2. Establish the feasibility of study design/methods of the HAPPINESS trial in adults with SCI (at least 50% of diverse backgrounds) through pre-specified targets for recruitment/enrollment, feasibility, and acceptability of design and outcomes. Using a Phase I randomized controlled trial design, 40 adults with SCI-related neuropathic pain will be randomized to 12-week remote Qigong intervention OR a short daily pain management survey that can be completed on phone/iPad/computer + 6-month follow-up. The study results will facilitate a rigorous structure to design larger effectiveness studies and facilitate a clear pathway for researchers to investigate Qigong and other mind-body approaches for whole-person health in diverse groups of adults with chronic/neurological disorders.

03

Conditions studied

  • Spinal Cord Injuries
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18+ years old
  • medically stable
  • with neuropathic pain 4 or above on the numeric pain rating scale + screened with painDETECT
  • willing to participate in a remote Qigong intervention (from any location with internet connection)
  • fluent in English or Spanish
  • access to the internet and a computer/iPad or smartphone

Exclusion criteria

Exclusion Criteria:

  • uncontrolled seizure disorder
  • cognitive impairment and/or communicative disability (e.g., due to brain injury) preventing them from following directions or from learning
  • ventilator dependency
  • major medical complications
  • pressure ulcers hindering prolonged sitting or lying down
  • (planning to become) pregnant or planning a major surgery during the study (given study duration, regular Qigong practice, and frequent check-ins)
  • regular Tai Chi or Qigong practice in the past 6 months (3x/week or more)
  • currently engaged in other rehabilitation programs that would influence outcomes
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Experimental group

    adults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to experimental group

    Behavioral: Qigong

  • Active comparator
    Active comparison group

    adults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to active comparator group

    Behavioral: Daily 2 min pain management survey

Interventions

  • BehavioralQigong

    a Qigong introduction class and a 12-week remote Qigong intervention, with a 6-month follow-up

  • BehavioralDaily 2 min pain management survey

    Completing one short survey (2 min) daily through your phone or computer (you will get a survey link through email or text), with a 6-month follow-up.

06

What researchers measure

Primary outcomes

  1. recruitment rates

    The proportion of potential participants contacted who agreed to participate

    Time frame: 6 months post-intervention

  2. the recruitment rate for complete and incomplete SCI

    Ratio of complete/incomplete SCI.

    Time frame: 6 months post-intervention

  3. Attrition rates in Qigong and Manage My Pain app group.

    Proportion of people withdrawing from the study in either group. Drop-out due to unrelated reasons will count as part of the general attrition.

    Time frame: 6 months post-intervention

  4. intervention adherence

    the website log times will indicate the date and duration that the video is accessed. From this information, we will collect the number of minutes that they practice. This information will be checked with the self-report during the weekly calls, in which they will report the number of minutes per week they have practiced.

    Time frame: 6 months post-intervention

  5. the frequency of use of the Manage My Pain app (recommended daily check in)

    Weekly/ monthly check-ins (reporting min/week of practice) to identify facilitators and barriers to practicing Qigong. The website logs time and duration of video access. A Qigong certified instructor will do 1:1 Qigong session with each participant via zoom monthly for quality control/to give guidance.

    Time frame: 6 months post-intervention

  6. Feasibility of adhering to the collection of quantitative measure 1

    % Adherence in completing all assessments during the study and in the monthly follow-up phase

    Time frame: 6 months post-intervention

  7. Feasibility of adhering to the collection of quantitative measure 2

    % Adherence to wearing Fitbit Charge 6 and sending the data through their phone App

    Time frame: 6 months post-intervention

07

Study locations

1 of 3 sites recruiting
08

References and documents

Publications

  • Van de Winckel A, Zhang L, Lim KO, Morse LR, Woodliff B, Maestre G, Baker K. Changing the Perceived Pain Intensity in Populations With Spinal Cord Injury and With Health Disparities (HAPPINESS): Protocol for a Feasibility Study. JMIR Res Protoc. 2025 Nov 19;14:e82431. doi: 10.2196/82431. PubMed 41259096 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Jan 2027, 29 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 29 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2023
First posted
Nov 20, 2023
StartActual
Aug 20, 2024
Primary completionEst.
Jan 31, 2027
CompletionEst.
Jan 31, 2027
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06140355
Responsible party
Sponsor
First posted
Nov 20, 2023
Start date
Aug 20, 2024
Primary completion
Jan 31, 2027 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Aug 19, 2026

Study contacts

Ann Van de Winckel, PhD, MSPT, PT
Contact
avandewi@umn.edu
612-625-1191
Ann Van de Winckel, PhD, MSPT, PT
principal investigator · University of Minnesota

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion